MMSE score |
26+ |
>20 |
10–19 |
<9 |
Average duration of disease stage |
4–10 Years |
2–4 Years |
2–10 Years |
1–3 Years |
Behavioral/Psychological symptoms reported |
Apathy, Anhedonia |
Apathy, Depression, some Anxiety |
Apathy, Delusions, Major Depression, Anxiety, Insomnia, Agitation, Comprehension, Aggression |
Apathy, decreased Depression, IADLs affected, Psychosis, Aggression, Agitation, Comprehension, worsened Insomnia |
Current pharmacological therapies |
Acetylcholinesterase Inhibitors, Donepezil |
Acetylcholinesterase Inhibitors, Methylphenidate, SSRIs/SNRIs, Antidepressants, Carbamazepine, Donepezil |
SSRIs/SNRIs, Lecanemab, Brexpirpazole, Benzodiazepines, Atypical Antipsychotics, Antidepressants |
Atypical Antipsychotics, Benzodiazepines, Antidepressants |